News

Immune responses rely on the efficient movement of immune cells within the complex and geometrically unpredictable ...
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue from sales ...